Trabectedin for inoperable or recurrent soft tissue sarcoma in adult patients: a retrospective cohort study

被引：0
作者：
Fernando A. Angarita
Amanda J. Cannell
Albiruni R. Abdul Razak
Brendan C. Dickson
Martin E. Blackstein
机构：
[1] University of Toronto,Division of General Surgery, Department of Surgery
[2] Mount Sinai Hospital,Department of Medical Oncology
[3] Princess Margaret Cancer Centre,Department of Medical Oncology
[4] University Health Network,Department of Medicine
[5] University of Toronto,Department of Pathology and Laboratory Medicine
[6] Mount Sinai Hospital,Department of Laboratory Medicine and Pathobiology
[7] University of Toronto,undefined
来源：
BMC Cancer | / 16卷
关键词：
Overall Survival; Soft Tissue Sarcoma; Partial Remission; Leiomyosarcoma; Liposarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[41]   Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials [J].
Cesne, A. L. ;
Judson, I. ;
Maki, R. ;
Grosso, F. ;
Schuetze, S. ;
Mehren, M. V. ;
Chawla, S. P. ;
Demetri, G. D. ;
Nieto, A. ;
Tanovic, A. ;
Blay, J-Y .
BRITISH JOURNAL OF CANCER, 2013, 109 (07) :1717-1724
[42]   Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma [J].
Thornton, Katherine A. .
CORE EVIDENCE, 2009, 4 :191-198
[43]   The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS) [J].
F. Ploner ;
W. Lamm ;
S. Schur ;
W. Eisterer ;
T. Kühr ;
A. Lindorfer ;
C. Tinchon ;
W. J. Köstler ;
J. Szkandera ;
T. Brodowicz .
Journal of Cancer Research and Clinical Oncology, 2013, 139 :1337-1342
[44]   Exatecan in pretreated adult patients with advanced soft tissue sarcoma:: Results of a phase II -: Study of the EORTC Soft Tissue and Bone Sarcoma Group [J].
Reichardt, P. ;
Nielsen, O. S. ;
Bauer, S. ;
Hartmann, J. T. ;
Schoffski, P. ;
Christensen, T. B. ;
Pink, D. ;
Daugaard, S. ;
Marreaud, S. ;
van Glabbeke, M. ;
Blay, J. Y. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (06) :1017-1022
[45]   Trabectedin A Review of its Use in Soft Tissue Sarcoma and Ovarian Cancer [J].
Carter, Natalie J. ;
Keam, Susan J. .
DRUGS, 2010, 70 (03) :355-376
[46]   Trabectedin Cardiotoxicity in Soft Tissue Sarcoma: A Case Series and Clinical Insights [J].
Gent, David G. ;
Ali, Nasim ;
Olsson-Brown, Anna ;
Lip, Gregory Y. H. ;
Wright, David J. ;
Dobson, Rebecca .
CASE REPORTS IN ONCOLOGY, 2022, 15 (03) :950-959
[47]   Anlotinib treatment in elderly patients with unresectable or metastatic soft tissue sarcoma: a retrospective study [J].
Zhang, Xin-Yao ;
Liu, Jie ;
Deng, Yao-Tiao ;
Jiang, Yu .
ANTI-CANCER DRUGS, 2022, 33 (01) :E519-E524
[48]   Integrating therapies for surgical adult soft tissue sarcoma patients [J].
Milgrom, Daniel P. ;
Sehdev, Amikar ;
Kays, Joshua K. ;
Koniaris, Leonidas G. .
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 3
[49]   The Relationship Between Area-Level Marginalization and Overall Survival of Patients with Soft Tissue Sarcoma in Ontario: A Retrospective Cohort Study [J].
Tellios, Vasiliki ;
Gazendam, Aaron ;
Griffin, Anthony ;
Wunder, Jay ;
Tsoi, Kim ;
Ferguson, Peter .
ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (05) :3716-3723
[50]   Temporal variation in nutritional status and preoperative anemia among patients with retroperitoneal soft tissue sarcoma: a retrospective longitudinal cohort study [J].
Willis, Franziska ;
Trunk, Anna-Marlen ;
Musa, Julian ;
Harnoss, Jonathan M. ;
Strowitzki, Moritz J. ;
Engerer, Cosima ;
Harnoss, Julian-C. ;
Al-Saeedi, Mohammed ;
Buechler, Markus W. ;
Schneider, Martin .
LANGENBECKS ARCHIVES OF SURGERY, 2025, 410 (01)
12345